Novartis has expanded its presence in the field of cell therapy with the signing of a research collaboration with Regenerex LLC to investigate applications of the US company’s haematopoietic stem cell-based platform. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
